NDC 61825-302 – Orphengesic Forte
Orphenadrine Citrate 50 mg/1; Aspirin 770 mg/1; Caffeine 60 mg/1 · Tablet · Oral
Product NDC61825-302
Product details
- Brand name
- Orphengesic Forte
- Generic name
- Orphenadrine Citrate, Aspirin and Caffeine
- Labeler
- Galt Pharmaceuticals, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA075141
- Marketed since
- June 8, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Central Nervous System Stimulant; Methylxanthine; Muscle Relaxant; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor
Active ingredients
- Orphenadrine Citrate 50 mg/1
- Aspirin 770 mg/1
- Caffeine 60 mg/1
Uses, dosage, side effects and warnings for Orphengesic Forte →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61825-302-60 | 60 TABLET in 1 BOTTLE, PLASTIC (61825-302-60) | Jun 8, 2020 |